Does NITROGLYCERIN Cause Interstitial lung disease? 18 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Interstitial lung disease have been filed in association with NITROGLYCERIN (Glonoinum). This represents 0.2% of all adverse event reports for NITROGLYCERIN.
18
Reports of Interstitial lung disease with NITROGLYCERIN
0.2%
of all NITROGLYCERIN reports
0
Deaths
5
Hospitalizations
How Dangerous Is Interstitial lung disease From NITROGLYCERIN?
Of the 18 reports, 5 (27.8%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NITROGLYCERIN. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does NITROGLYCERIN Cause?
Drug ineffective (1,269)
Fall (1,183)
Hypotension (1,086)
Pain (952)
Constipation (896)
Headache (890)
Dyspnoea (801)
Malaise (765)
Dizziness (717)
Fatigue (680)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which NITROGLYCERIN Alternatives Have Lower Interstitial lung disease Risk?
NITROGLYCERIN vs NITROUS
NITROGLYCERIN vs NITROUS\OXYGEN
NITROGLYCERIN vs NIVOLUMAB
NITROGLYCERIN vs NIVOLUMAB\RELATLIMAB-RMBW
NITROGLYCERIN vs NIZATIDINE